Low-molecular-weight heparin-induced skin necrosis: a potential association with pre-existent hypercoagulable states.
Toll
Agustí
A
Department of Dermatology, Hospital del Mar, Barcelona, Spain.
Gallardo
Fernando
F
Abella
M Eugenia
ME
Fontcuberta
Jaume
J
Barranco
Carlos
C
Pujol
Ramon M
RM
D000368:Aged; D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017984:Enoxaparin / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007150:Immunohistochemistry; D007279:Injections, Subcutaneous; D008297:Male; D009336:Necrosis / Q000139:chemically induced / Q000473:pathology; D018570:Risk Assessment; D012720:Severity of Illness Index; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology*; D013923:Thromboembolism / Q000517:prevention & control*
D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight